{"id":22250,"date":"2020-06-29T07:34:42","date_gmt":"2020-06-29T07:34:42","guid":{"rendered":"https:\/\/positivelysharing.org\/blog\/?p=22250"},"modified":"2020-06-29T07:34:42","modified_gmt":"2020-06-29T07:34:42","slug":"gilead-terminates-license-agreement-for-long-acting-injectable-hiv-investigational-product","status":"publish","type":"post","link":"https:\/\/positivelysharing.org\/blog\/2020\/06\/29\/gilead-terminates-license-agreement-for-long-acting-injectable-hiv-investigational-product\/","title":{"rendered":"Gilead Terminates License Agreement for Long-Acting Injectable HIV Investigational Product"},"content":{"rendered":"<span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span><p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-21937\" src=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/Depo-provera-injection-300x162.png\" alt=\"\" width=\"300\" height=\"162\" srcset=\"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/Depo-provera-injection-300x162.png 300w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/Depo-provera-injection-500x270.png 500w, https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/Depo-provera-injection.png 624w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p><a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2842980-1&amp;h=3653518981&amp;u=http%3A%2F%2Fwww.durect.com%2F&amp;a=DURECT+Corporation\" target=\"_blank\" rel=\"nofollow noopener noreferrer\">DURECT Corporation<\/a><span style=\"display: inline !important; float: none; background-color: #ffffff; color: #373737; font-family: 'Montserrat',Helvetica,Arial,sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.8; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\"> (Nasdaq: <\/span><a class=\"ticket-symbol\" href=\"https:\/\/www.prnewswire.com\/news-releases\/gilead-terminates-license-agreement-for-long-acting-injectable-hiv-investigational-product-301084574.html#financial-modal\">DRRX<\/a><span style=\"display: inline !important; float: none; background-color: #ffffff; color: #373737; font-family: 'Montserrat',Helvetica,Arial,sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.8; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">) today announced that Gilead Sciences, Inc., (Gilead) has provided notice that, effective as of <\/span><span class=\"xn-chron\">December 22, 2020<\/span><span style=\"display: inline !important; float: none; background-color: #ffffff; color: #373737; font-family: 'Montserrat',Helvetica,Arial,sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; line-height: 1.8; orphans: 2; text-align: left; text-decoration: none; text-indent: 0px; text-transform: none; -webkit-text-stroke-width: 0px; white-space: normal; word-spacing: 0px;\">, it is terminating the License Agreement dated <\/span><span class=\"xn-chron\">July 19, 2019 <a href=\"https:\/\/www.prnewswire.com\/news-releases\/gilead-terminates-license-agreement-for-long-acting-injectable-hiv-investigational-product-301084574.html\">Read More<\/a><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p><span class=\"span-reading-time rt-reading-time\" style=\"display: block;\"><span class=\"rt-label rt-prefix\">Reading Time: <\/span> <span class=\"rt-time\"> &lt; 1<\/span> <span class=\"rt-label rt-postfix\">minute<\/span><\/span>DURECT Corporation (Nasdaq: DRRX) today announced that Gilead Sciences, Inc., (Gilead) has provided notice that, effective as of December 22, 2020, it&#8230;<\/p>\n","protected":false},"author":1,"featured_media":21937,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[159],"tags":[],"class_list":{"0":"post-22250","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-hiv-2"},"jetpack_featured_media_url":"https:\/\/positivelysharing.org\/blog\/wp-content\/uploads\/2020\/06\/Depo-provera-injection.png","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/22250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/comments?post=22250"}],"version-history":[{"count":1,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/22250\/revisions"}],"predecessor-version":[{"id":22251,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/posts\/22250\/revisions\/22251"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media\/21937"}],"wp:attachment":[{"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/media?parent=22250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/categories?post=22250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/positivelysharing.org\/blog\/wp-json\/wp\/v2\/tags?post=22250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}